02975nas a2200301 4500000000100000008004100001653001000042653001600052653002800068653002100096100001200117700001400129700001300143700001400156700001500170700001400185700001100199700001400210700001300224700001400237700001400251245014600265856013700411300001300548490000700561520209100568022001402659 2019 d10aEbola10aEbola virus10aStigma (health related)10aStigma reduction1 aKelly D1 aWeiser SD1 aWilson B1 aCooper JB1 aGlayweon M1 aSneller M1 aDrew C1 aSteward W1 aReilly C1 aJohnson K1 aFallah MP00aEbola virus disease-related stigma among survivors declined in Liberia over an 18-month, post-outbreak period: An observational cohort study. uhttps://www.ncbi.nlm.nih.gov/pubmed/?term=Ebola+virus+disease-related+stigma+among+survivors+declined+in+Liberia+over+an+18-month%2C ae00071850 v133 a

BACKGROUND: While qualitative assessments of Ebola virus disease (EVD)-related stigma have been undertaken among survivors and the general public, quantitative tools and assessment targeting survivors have been lacking.

METHODS AND FINDINGS: Beginning in June 2015, EVD survivors from seven Liberian counties, where most of the country's EVD cases occurred, were eligible to enroll in a longitudinal cohort. Seven stigma questions were adapted from the People Living with HIV Stigma Index and asked to EVD survivors over the age of 12 at initial visit (median 358 days post-EVD) and 18 months later. Primary outcome was a 7-item EVD-related stigma index. Explanatory variables included age, gender, educational level, pregnancy status, post-EVD hospitalization, referred to medical care and EVD source. Proportional odds logistic regression models and generalized linear mixed-effects models were used to assess stigma at initial visit and over time. The stigma questions were administered to 859 EVD survivors at initial visit and 741 (86%) survivors at follow-up. While 63% of survivors reported any stigma at initial visit, only 5% reported any stigma at follow-up. Over the 18-month period, there was a significant decrease in stigma among EVD survivors (Adjusted Odds Ratio [AOR], 0.02; 95% Confidence Interval [CI], 0.01-0.04). At initial visit, having primary, junior high or vocational education, and being referred to medical care was associated with higher odds of stigma (educational level: AOR, 1.82; 95%CI, 1.27-2.62; referred: AOR, 1.50; 95%CI, 1.16-1.94). Compared to ages of 20-29, those who had ages of 12-19 or 50+ experienced lower odds of stigma (12-19: AOR, 0.32; 95%CI, 0.21-0.48; 50+: AOR, 0.58 95%CI, 0.37-0.91).

CONCLUSIONS: Our data suggest that EVD-related stigma was much lower more than a year after active Ebola transmission ended in Liberia. Among survivors who screened negative for stigma, additional probing may be considered based on age, education, and referral to care.

 a1935-2735